Lysophosphatidic acid receptor signaling by CD8 T cells promoted tolerogenic states via metabolic reprogramming and potentiating exhaustive-like differentiation to modulate anti-tumor immunity.
[Nature Communications]
Home Newsletters Cell Therapy News Lysophosphatidic Acid Modulates CD8 T Cell Immunosurveillance and Metabolism To Impair Anti-Tumor...
